Accolade, Inc. (ACCD)
After hours:
| Previous Close | 26.58 |
| Open | 26.84 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 1400 |
| Day's Range | 25.11 - 27.24 |
| 52 Week Range | 25.11 - 65.25 |
| Volume | |
| Avg. Volume | 579,311 |
| Market Cap | 1.711B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
Accolade to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
SEATTLE, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves over 400 employers and millions of members, will participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference. A presentation is available for registered attendees via the Piper Sandler conference site until December 2, 2021 or can also be accessed at ir.accolade.com. About Accolade, Inc. Accolade (Nasdaq: ACCD) provides millions of people and their families with an exception
- GlobeNewswire
Accolade to Participate in the Credit Suisse 30th Annual Healthcare Conference
SEATTLE, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves over 400 employers and millions of members, will participate in the Credit Suisse 30th Annual Healthcare Conference, including a fireside chat presentation on Thursday, November 11, 2021 at 12:10 p.m. E.T. A webcast and related presentation materials will be available at ir.accolade.com. About Accolade, Inc. Accolade (Nasdaq: ACCD) provides millions of people and their families with an exc
- GlobeNewswire
Accolade Announces Results for Fiscal Second Quarter 2022
Fiscal second quarter 2022 revenue of $73.3 million, a 99% increase compared to fiscal second quarter 2021 revenue of $36.8 million Introduced Personalized Healthcare category, focused on human relationships and personalization using data to enable value-based careLaunched Accolade One and Accolade Care, two new healthcare solutions that combine Accolade’s intelligent technology, advocacy services and team-based healthcare delivery SEATTLE, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDA
